| Title | Medical management of the pregnant patient with inflammatory bowel disease. |
| Publication Type | Journal Article |
| Year of Publication | 2004 |
| Authors | Steinlauf AF, Present DH |
| Journal | Gastroenterol Clin North Am |
| Volume | 33 |
| Issue | 2 |
| Pagination | 361-85, xi |
| Date Published | 2004 Jun |
| ISSN | 0889-8553 |
| Keywords | 6-Mercaptopurine, Adrenal Cortex Hormones, Anti-Bacterial Agents, Anti-Inflammatory Agents, Non-Steroidal, Antibodies, Monoclonal, Azathioprine, Female, Humans, Immunosuppressive Agents, Inflammatory Bowel Diseases, Pregnancy, Pregnancy Complications |
| Abstract | Gastroenterologists are not infrequently faced with questions regarding pregnancy when advising or treating their patients with inflammatory bowel disease (IBD). To advise patients effectively, the following factors must be considered: (1) the inheritance patterns of IBD for accurate counseling and family planning; (2) the effects of active IBD versus medications or surgery on fertility; (3) the effects of pregnancy on the course of IBD; (4) the effects and potential risks of active IBD versus those of diagnostic tests, medical treatments, and surgical treatments on the developing fetus; (5) approach to delivery; and (6) the risks of breast-feeding while receiving treatment for IBD. |
| DOI | 10.1016/j.gtc.2004.02.013 |
| Alternate Journal | Gastroenterol. Clin. North Am. |
| PubMed ID | 15177544 |